MSLN-targeted CAR-T Cells in Solid Tumors.
NCT05783089
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
87
Enrollment
OTHER
Sponsor class
Conditions
Mesothelin-positive Advanced Malignant Solid Tumors
Interventions
BIOLOGICAL:
Anti-mesothelin CAR-T cells
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Collaborators
[object Object]